UCLE · As filed with the SEC
US Nuclear balance sheet, by fiscal year
The statement as US Nuclear presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD
| USD | FY2025 Dec 31, 2025 | FY2024 Dec 31, 2024 | FY2023 Dec 31, 2023 | FY2022 Dec 31, 2022 | FY2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash | — | — | — | 126,109 | 246,317 |
| Cash | — | — | 152,840 | — | — |
| Cash | — | 130,840 | — | — | — |
| Cash | 134,779 | — | — | — | — |
| Accounts receivable, net | 213,700 | 351,398 | 342,172 | 329,858 | 163,577 |
| Note receivable | 39,966 | 41,916 | 21,149 | — | — |
| Inventories | 1,083,083 | 1,536,014 | 1,761,783 | 2,024,664 | 1,792,312 |
| Prepaid expenses and other current assets | — | — | — | 26,370 | 44,026 |
| Prepaid expenses and other current assets | 5,630 | 10,000 | — | — | — |
| TOTAL CURRENT ASSETS | 1,477,158 | 2,070,168 | 2,277,944 | 2,507,001 | 2,246,232 |
| Property and equipment, net | 524 | 1,964 | 4,217 | 6,501 | 9,719 |
| Investments | 4,539 | 4,539 | 4,539 | 10,059 | 10,059 |
| Acquisition deposit | — | — | — | 15,000 | 15,000 |
| Goodwill | 439,662 | 570,176 | 570,176 | 570,176 | 570,176 |
| TOTAL ASSETS | 1,921,883 | 2,646,847 | 2,856,876 | 3,108,737 | 2,851,186 |
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||
| CURRENT LIABILITIES | |||||
| Accounts payable | 217,440 | 256,276 | 207,929 | 100,398 | 91,859 |
| Accounts payable - related party | — | — | — | 280,000 | 128,500 |
| Related Party | — | — | 456,000 | — | — |
| Accrued liabilities | 1,171,321 | 1,025,954 | 1,020,743 | 688,422 | 587,941 |
| Accrued compensation - officers | 13,000 | 13,000 | 860,000 | 695,000 | 590,000 |
| Customer deposit | — | — | 6,771 | 88,694 | 101,342 |
| Deferred revenue | — | — | 51,578 | — | — |
| Customer deposit | — | 423,548 | — | — | — |
| Customer deposit | 117,496 | — | — | — | — |
| Notes payable | 181,924 | 169,624 | 104,308 | 9,574 | 48,541 |
| Convertible notes payable, net of debt discount | 0 | 405,403 | 600,614 | 412,953 | — |
| Note payable to shareholder | — | — | — | 874,679 | 576,260 |
| Shareholder | — | — | 1,220,279 | — | — |
| Note payable to shareholder | 90,330 | 92,512 | — | — | — |
| Line of credit | 384,630 | 311,273 | 311,273 | 307,321 | 285,474 |
| TOTAL CURRENT LIABILITIES | 2,176,141 | 2,697,590 | 4,839,495 | 3,457,041 | 2,409,917 |
| LONG-TERM LIABILITIES | |||||
| Notes payable | 184,433 | 805,422 | — | — | — |
| Convertible notes payable | 75,000 | — | — | — | — |
| TOTAL LONG-TERM LIABILITIES | 259,433 | 805,422 | — | — | — |
| TOTAL LIABILITIES | 2,435,574 | 3,503,012 | 4,839,495 | 3,457,041 | 2,409,917 |
| SHAREHOLDERS’ DEFICIT: | |||||
| Preferred stock, Series A, $0.0001 par value, 10,000 shares authorized, 2,656 and -0- shares issued and outstanding | 266 | — | — | — | — |
| Preferred shares to be issued (2,006 shares) | — | 2,006,000 | — | — | — |
| Common stock, $0.0001 par value; 100,000,000 shares authorized, 62,822,263 and 52,712,778 shares issued and outstanding | 6,283 | 5,271 | 4,017 | 3,162 | 2,836 |
| Common shares to be issued (572,660 shares) | — | 45,813 | — | — | — |
| Common shares to be issued | 150,060 | — | 126,000 | 39,000 | — |
| Additional paid in capital | — | — | 16,454,048 | — | — |
| Additional paid-in capital | 20,478,838 | 16,763,076 | — | 14,740,401 | 13,508,581 |
| Accumulated deficit | (21,149,138) | (19,676,325) | (18,566,684) | (15,130,867) | (13,070,148) |
| TOTAL SHAREHOLDERS’ DEFICIT | (513,691) | (856,165) | (1,982,619) | (348,304) | 441,269 |
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT | 1,921,883 | 2,646,847 | 2,856,876 | 3,108,737 | 2,851,186 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.